You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

Jubilant Company Profile


✉ Email this page to a colleague

« Back to Dashboard


What is the competitive landscape for JUBILANT, and what generic and branded alternatives to JUBILANT drugs are available?

JUBILANT has seventy-six approved drugs.



Summary for Jubilant
US Patents:0
Tradenames:68
Ingredients:64
NDAs:76

Drugs and US Patents for Jubilant

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Jubilant Generics OLANZAPINE olanzapine TABLET, ORALLY DISINTEGRATING;ORAL 200221-003 Sep 12, 2012 AB RX No No ⤷  Subscribe ⤷  Subscribe
Jubilant Generics VALACYCLOVIR HYDROCHLORIDE valacyclovir hydrochloride TABLET;ORAL 201506-001 Apr 3, 2012 AB RX No No ⤷  Subscribe ⤷  Subscribe
Jubilant Cadista CLOMIPRAMINE HYDROCHLORIDE clomipramine hydrochloride CAPSULE;ORAL 212218-003 Oct 21, 2019 AB RX No No ⤷  Subscribe ⤷  Subscribe
Jubilant Generics AMLODIPINE AND OLMESARTAN MEDOXOMIL amlodipine besylate; olmesartan medoxomil TABLET;ORAL 207450-003 May 15, 2017 DISCN No No ⤷  Subscribe ⤷  Subscribe
Jubilant Generics MONTELUKAST SODIUM montelukast sodium TABLET, CHEWABLE;ORAL 203795-001 Feb 27, 2015 DISCN No No ⤷  Subscribe ⤷  Subscribe
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.